We still struggle to know how to best treat patients suffering from Ebola virus disease.
At the onset of the 2013–2016 epidemic of Ebola virus disease (EVD), no antiviral medication was approved for treatment. Therefore, doctors and researchers came up with the idea of trying Amiodarone.
Amiodarone, normally used for the treatment of cardiac arrhythmia, was reported to inhibit Ebola filovirus entry. Although amiodarone had activity in different cell types, a recent study conducted by Dr. Julie Dyall and colleagues demonstrated that amiodarone did not protect guinea pigs from a lethal dose of Ebola virus.
I think we need a global campaign to raise money to develop an effective vaccine against Ebola. What do you think? Please leave comments below or share on social media.
Best regards, Phil Lederer